| Report Title | Price | Action |
|---|---|---|
| Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021
Peripheral Neuropathy (Sensory Neuropathy) (Central Nervous System) - Drugs in Development, 2021 Summary Peripheral Neuropathy (Sensory Neuropathy) ...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021
Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Charcot-Marie-Tooth Disease (Genetic Disorders) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase (UDP-3-O-Acyl-N-Acetylglucosamine Deacetylase or Protein EnvA or lpxC or EC 3.5.1.108) - Drugs in Development, 2021
UDP-3-O-[3-Hydroxymyristoyl] N-Acetylglucosamine Deacetylase (UDP-3-O-Acyl-N-Acetylglucosamine Deacetylase or Protein EnvA or lpxC or EC 3.5.1.108) - ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021
Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) - Drugs in Development, 2021 Summary Middle East Respiratory Syndrome coronav...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Fibronectin (Cold Insoluble Globulin or FN1) - Drugs in Development, 2021
Fibronectin (Cold Insoluble Globulin or FN1) - Drugs in Development, 2021 Summary Fibronectin (Cold Insoluble Globulin or FN1) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Development, 2021
Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Development, 2021 Summary Thymoma (Thymic Epithelial Tumor) (Oncology) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021
Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Development, 2021 Summary Central Retinal Vein Occlusion (Ophthalmology) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Radiation Injury (Toxicology) - Drugs in Development, 2021
Radiation Injury (Toxicology) - Drugs in Development, 2021 Summary Radiation Injury (Toxicology) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021
Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Development, 2021 Summary Peripheral T-Cell Lymphomas (PTCL) (Oncology) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 180
|
$ 2500 | |
| Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021
Chemotherapy Induced Myelosuppression (Oncology) - Drugs in Development, 2021 Summary Chemotherapy Induced Myelosuppression (Oncology) - Drugs in De...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 or EC 2.7.10.2) - Drugs in Development, 2021
Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 or EC 2.7.10.2) - Drugs in Development, 2021 Summary Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Nitric Oxide Synthase Inducible (Hepatocyte NOS or Inducible NO Synthase or Peptidyl Cysteine S Nitrosylase NOS2 or NOS Type II or NOS2 or EC 1.14.13.39) - Drugs in Development, 2021
Nitric Oxide Synthase Inducible (Hepatocyte NOS or Inducible NO Synthase or Peptidyl Cysteine S Nitrosylase NOS2 or NOS Type II or NOS2 or EC 1.14.13....
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Galanin Receptor Type 2 (GALR2) - Drugs in Development, 2021
Galanin Receptor Type 2 (GALR2) - Drugs in Development, 2021 Summary Galanin Receptor Type 2 (GALR2) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Sleep Disorders (Central Nervous System) - Drugs in Development, 2021
Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Sleep Disorders (Central Nervous System) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Choroideremia (Ophthalmology) - Drugs in Development, 2021
Choroideremia (Ophthalmology) - Drugs in Development, 2021 Summary Choroideremia (Ophthalmology) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021
Kennedy's Disease (Spinal and Bulbar Muscular Atrophy) (Genetic Disorders) - Drugs in Development, 2021 Summary Kennedy's Disease (Spinal and Bulbar...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs in Development, 2021
Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs in Development, 2021 Summary Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) - Drugs i...
Published: Apr-2021 | No. of Pages: 210
|
$ 2500 | |
| Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021
Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021 Summary Chlamydia Trachomatis Infections (Infectious Disease) - D...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Alpha 1A Adrenergic Receptor (Alpha 1A Adrenoreceptor or Alpha 1C Adrenergic Receptor or Alpha Adrenergic Receptor 1c or ADRA1A) - Drugs in Development, 2021
Alpha 1A Adrenergic Receptor (Alpha 1A Adrenoreceptor or Alpha 1C Adrenergic Receptor or Alpha Adrenergic Receptor 1c or ADRA1A) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Opioid Receptor (OPR) - Drugs in Development, 2021
Opioid Receptor (OPR) - Drugs in Development, 2021 Summary Opioid Receptor (OPR) - Drugs in Development, 2021 provides in depth analysis on Opioid R...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 |